Effect of Prefrontal Cortex Stimulation on Regulation of Amygdala Response to Threat in Individuals With Trait Anxiety: A Randomized Clinical Trial.
Adolescent
Adult
Amygdala
/ physiopathology
Anxiety
/ physiopathology
Attention
/ physiology
Double-Blind Method
Fear
/ physiology
Female
Humans
Magnetic Resonance Imaging
Neural Inhibition
/ physiology
Neural Pathways
/ physiopathology
Neuroimaging
Prefrontal Cortex
/ physiology
Transcranial Direct Current Stimulation
Young Adult
Journal
JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550
Informations de publication
Date de publication:
01 01 2019
01 01 2019
Historique:
pubmed:
23
10
2018
medline:
18
2
2020
entrez:
23
10
2018
Statut:
ppublish
Résumé
Transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC) is under clinical investigation as a treatment for major depressive disorder. However, the mechanisms of action are unclear, and there is a lack of neuroimaging evidence, particularly among individuals with affective dysfunction. Furthermore, there is no direct causal evidence among humans that the prefrontal-amygdala circuit functions as described in animal models (ie, that increasing activity in prefrontal cortical control regions inhibits amygdala response to threat). To determine whether stimulation of the prefrontal cortex reduces amygdala threat reactivity in individuals with trait anxiety. This community-based randomized clinical trial used a double-blind, within-participants design (2 imaging sessions per participant). Eighteen women with high trait anxiety (age range, 18-42 years) who scored greater than 45 on the trait measure of State-Trait Anxiety Inventory were randomized to receive active or sham tDCS of the DLPFC during the first session and the other intervention during the next session. Each intervention was followed immediately by a functional imaging scan during which participants performed an attentional task requiring them to ignore threatening face distractors. Data were collected from May 7 to October 6, 2015. Amygdala threat response, measured with functional magnetic resonance imaging. Data from 16 female participants (mean age, 23 years; range, 18-42 years), with 8 in each group, were analyzed. Compared with sham stimulation, active DLPFC stimulation significantly reduced bilateral amygdala threat reactivity (z = 3.30, P = .04) and simultaneously increased activity in cortical regions associated with attentional control (z = 3.28, P < .001). In confirmatory behavioral analyses, there was a mean improvement in task accuracy of 12.2% (95% CI, 0.30%-24.0%; mean [SD] difference in number of correct answers, 2.2 [4.5]; t15 = 1.94, P = .04) after active DLPFC stimulation. These results reveal a causal role for prefrontal regulation of amygdala function in attentional capture by threat in individuals with high trait anxiety. The finding that prefrontal stimulation acutely increases attentional control signals and reduces amygdala threat reactivity may indicate a neurocognitive mechanism that could contribute to tDCS treatment effects in affective disorders. isrctn.org Identifier: ISRCTN78638425.
Identifiants
pubmed: 30347011
pii: 2707242
doi: 10.1001/jamapsychiatry.2018.2172
pmc: PMC6583758
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
71-78Subventions
Organisme : Medical Research Council
ID : MR/N008103/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH091848
Pays : United States
Références
Biol Psychiatry. 2007 Jan 15;61(2):198-209
pubmed: 17027931
J Neurosci. 2003 Sep 24;23(25):8800-7
pubmed: 14507980
PLoS One. 2015 Apr 24;10(4):e0124182
pubmed: 25909846
Biol Psychiatry. 2014 Dec 15;76(12):946-52
pubmed: 24690113
Sci Rep. 2017 Feb 02;7:41603
pubmed: 28148969
Psychol Med. 2012 Sep;42(9):1791-800
pubmed: 22236735
Neuroimage. 2002 Oct;17(2):825-41
pubmed: 12377157
Curr Opin Behav Sci. 2015 Feb;1:32-39
pubmed: 27398396
Arch Gen Psychiatry. 2002 May;59(5):425-33
pubmed: 11982446
Arch Gen Psychiatry. 2010 Nov;67(11):1128-38
pubmed: 21041614
J Physiol. 1964 Aug;172:369-82
pubmed: 14199369
Neuropsychopharmacology. 2004 Aug;29(8):1573-8
pubmed: 15199378
Cognition. 2015 Dec;145:73-6
pubmed: 26319971
Soc Cogn Affect Neurosci. 2017 Feb 1;12(2):251-260
pubmed: 27531388
J Neurosci. 2012 Apr 18;32(16):5631-7
pubmed: 22514324
Cogn Affect Behav Neurosci. 2017 Oct;17(5):1048-1057
pubmed: 28766117
Trends Cogn Sci. 2005 Feb;9(2):75-82
pubmed: 15668100
Neurosci Lett. 2015 Mar 30;591:126-31
pubmed: 25708347
Br J Psychiatry. 2007 Jun;190:531-2
pubmed: 17541115
Brain. 2002 Oct;125(Pt 10):2238-47
pubmed: 12244081
Psychol Med. 2012 Dec;42(12):2609-17
pubmed: 22716999
J Neurosci. 2011 Oct 26;31(43):15284-93
pubmed: 22031874
Nat Rev Neurosci. 2002 Mar;3(3):201-15
pubmed: 11994752
Hum Brain Mapp. 2014 Aug;35(8):3673-86
pubmed: 24453107
Neuron. 2005 Oct 20;48(2):175-87
pubmed: 16242399
Cereb Cortex. 2015 Mar;25(3):609-18
pubmed: 24062316
Biol Psychiatry. 2000 May 1;47(9):769-76
pubmed: 10812035
Br J Psychiatry. 2016 Jun;208(6):522-31
pubmed: 27056623
Behav Neurosci. 1997 Aug;111(4):683-91
pubmed: 9267646
Psychol Med. 2009 Jun;39(6):1019-28
pubmed: 18834555
Med Image Anal. 2001 Jun;5(2):143-56
pubmed: 11516708
Am J Psychiatry. 2003 May;160(5):835-45
pubmed: 12727683
Neurosci Lett. 1993 Nov 26;163(1):109-13
pubmed: 8295722
Cereb Cortex. 2007 Jul;17(7):1595-603
pubmed: 16956980
J Psychiatry Neurosci. 2009 Mar;34(2):119-26
pubmed: 19270762
Biol Psychiatry. 2006 May 1;59(9):816-20
pubmed: 16460693
Neuroreport. 2001 Aug 8;12(11):2543-7
pubmed: 11496145
Biol Psychol. 2010 Dec;85(3):487-95
pubmed: 20923694
Nat Neurosci. 2004 Feb;7(2):184-8
pubmed: 14703573
Psychophysiology. 1998 Sep;35(5):607-14
pubmed: 9715104
Arch Gen Psychiatry. 2005 Mar;62(3):282-8
pubmed: 15753241
JAMA Psychiatry. 2013 Apr;70(4):383-91
pubmed: 23389323
Am J Psychiatry. 2007 Oct;164(10):1476-88
pubmed: 17898336
Psychon Bull Rev. 2005 Apr;12(2):314-20
pubmed: 16082812
Am J Psychiatry. 2010 May;167(5):545-54
pubmed: 20123913
J Psychiatr Res. 2017 Oct;93:12-19
pubmed: 28554079
Am J Psychiatry. 2006 Nov;163(11):1905-17
pubmed: 17074942
Annu Rev Neurosci. 2000;23:155-84
pubmed: 10845062
J Psychiatr Res. 2011 Aug;45(8):1027-35
pubmed: 21439576
Am J Psychiatry. 2012 Jul;169(7):693-703
pubmed: 22535198
Soc Cogn Affect Neurosci. 2016 Dec;11(12):1992-1998
pubmed: 27510494
Biol Psychiatry. 2016 May 15;79(10):823-830
pubmed: 26210058
PLoS One. 2012;7(5):e35853
pubmed: 22586453
J Neurosci. 2006 Mar 8;26(10):2724-31
pubmed: 16525051